CoChat

Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment

Open access
Kim, Hyemin, Im, Ilkyun, Jeon, Jang Su, Kang, Eun-Hye, Lee, Hyang-Ae, Jo, Seongyea, Kim, Ji-Woo, Woo, Dong-Hun, Choi, Young Jae, Kim, Hyo Jin, Han, Ji-Seok, Lee, Byoung-Seok, Kim, Jong-Hoon, Kim, Sang Kyum, Park, Han-Jin · 2022 · Biomaterials
Cited by 81

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Abstract

Human in vitro hepatic models that faithfully recapitulate liver function are essential for successful basic and translational research. A limitation of current in vitro models, which are extensively used for drug discovery and toxicity testing, is the loss of drug metabolic function due to the low expression and activity of cytochrome P450 (CYP450) enzymes. Here, we aimed to generate human pluripotent stem cell-derived hepatic organoids (hHOs) with a high drug metabolic ability. We established a two-step protocol to produce hHOs from human pluripotent stem cells for long-term expansion and drug testing. Fully differentiated hHOs had multicellular composition and exhibited cellular polarity and hepatobiliary structures. They also displayed remarkable CYP450 activity and recapitulated the metabolic clearance, CYP450-mediated drug toxicity, and metabolism. Furthermore, hHOs successfully modeled Wilson's disease in terms of Cu metabolism, drug responses, and diagnostic marker expression and secretion. In conclusion, hHOs exhibit high capacity for drug testing and disease modeling. Hence, this hepatic model system provides an advanced tool for studying hepatic drug metabolism and diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biomaterials.2022.121575

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 81

Metadata

Authors
Kim, H., Im, I., Jeon, J. S., Kang, E.-H., Lee, H.-A., Jo, S., Kim, J.-W., Woo, D.-H., Choi, Y. J., Kim, H. J., Han, J.-S., Lee, B.-S., Kim, J.-H., Kim, S. K., & Park, H.-J.
Venue
Biomaterials
Publisher
Elsevier BV
Published
2022-07
Volume
286
Pages
121575
ISSN
0142-9612 (ISSN-L)
OpenAlex
W4280649004
Cited by
81
References
21
FWCI
4.28
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment. https://app.cochat.ai/papers/10.1016/j.biomaterials.2022.121575
The paper
Kim, H., Im, I., Jeon, J. S., Kang, E.-H., Lee, H.-A., Jo, S., Kim, J.-W., Woo, D.-H., Choi, Y. J., Kim, H. J., Han, J.-S., Lee, B.-S., Kim, J.-H., Kim, S. K., & Park, H.-J. (2022). Development of human pluripotent stem cell-derived hepatic organoids as an alternative model for drug safety assessment. Biomaterials. https://doi.org/10.1016/j.biomaterials.2022.121575

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.